Search Results for "Dry Eyes"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Dry Eyes. Results 61 to 70 of 72 total matches.

Elafibranor (Iqirvo) for Primary Biliary Cholangitis

   
The Medical Letter on Drugs and Therapeutics • Dec 23, 2024  (Issue 1718)
Elafibranor: el” a fi b’ ra nor Iqirvo: eye ker vo PPAR = peroxisome proliferator-activated receptor PBC ...
Elafibranor (Iqirvo – Ipsen), a peroxisome proliferator-activated receptor (PPAR) agonist, has been granted accelerated approval by the FDA for treatment of primary biliary cholangitis (PBC) in adults. It is indicated for use in combination with ursodeoxycholic acid (ursodiol, UDCA; Urso, and others) in patients with an inadequate response to UDCA alone and as monotherapy in those unable to tolerate UDCA.
Med Lett Drugs Ther. 2024 Dec 23;66(1718):202-4   doi:10.58347/tml.2024.1718b |  Show IntroductionHide Introduction

Ingenol Mebutate (Picato) for Actinic Keratoses

   
The Medical Letter on Drugs and Therapeutics • Apr 30, 2012  (Issue 1389)
changes and scarring were minimal. Periorbital edema, severe eye pain and eyelid ptosis can occur after ...
The FDA has approved ingenol mebutate (Picato – Leo) for topical treatment of actinic keratoses (AKs). The new drug is derived from the sap of the Euphorbia peplus plant, a traditional folk remedy for warts and other skin lesions.
Med Lett Drugs Ther. 2012 Apr 30;54(1389):35-6 |  Show IntroductionHide Introduction

Azelastine Nasal Spray for Allergic Rhinitis

   
The Medical Letter on Drugs and Therapeutics • May 09, 1997  (Issue 1000)
patients using a placebo spray. The drug also reduced eye symptoms, possibly due to systemic absorption ...
Azelastine hydrochloride, a histamine-H1 receptor antagonist, has been marketed as a 0.1% nasal spray (Astelin - Wallace) for treatment of seasonal allergic rhinitis. Corticosteroid and cromolyn sodium nasal sprays are also available for this indication (Medical Letter, 37:5, 1995). Cromolyn sodium (Nasalcrom) has now been approved for over-the-counter use.
Med Lett Drugs Ther. 1997 May 9;39(1000):45-7 |  Show IntroductionHide Introduction

Comparison Table: Some Lipid-Lowering Drugs (online only)

   
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022  (Issue 1659)
of peptic ulcers can occur ▶ Dry eyes and skin hyperpigmentation can occur rarely ▶ Flushing more common ...
View the Comparison Table: Some Lipid-Lowering Drugs
Med Lett Drugs Ther. 2022 Sep 19;64(1659):e152-6 |  Show IntroductionHide Introduction

Nabilone (Cesamet) for Chemotherapy-Induced Nausea and Vomiting

   
The Medical Letter on Drugs and Therapeutics • Dec 04, 2006  (Issue 1249)
, dry mouth and tachycardia are common adverse effects of nabilone. Orthostatic hypotension, euphoria ...
Nabilone, an oral synthetic cannabinoid similar to delta-9-tetrahydrocannabinol (THC), the active ingredient in marijuana, has recently been reintroduced to the US market (Cesamet - Valeant) after a 17-year absence. The previous manufacturer discontinued marketing of the drug for commercial reasons. Nabilone is classified as a Schedule II controlled substance.
Med Lett Drugs Ther. 2006 Dec 4;48(1249):103-4 |  Show IntroductionHide Introduction

Posaconazole (Noxafil) for Invasive Fungal Infections

   
The Medical Letter on Drugs and Therapeutics • Nov 20, 2006  (Issue 1248)
effects have been nausea, vomiting, diarrhea, abdominal pain and headache. Rash, dry skin, taste ...
Posaconazole (Noxafil - Schering-Plough), an oral azole antifungal with a chemical structure similar to that of itraconazole (Sporanox), has been approved by the FDA to prevent Candida and Aspergillus infections in severely immunocompromised patients and for treatment of oropharyngeal candidiasis. It is likely also to be used off-label for treatment of other fungal infections, including those caused by Mucor and other Zygomycetes.
Med Lett Drugs Ther. 2006 Nov 20;48(1248):93-5 |  Show IntroductionHide Introduction

Lipid-Lowering Drugs

   
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022  (Issue 1659)
, dry eyes or skin hyperpigmentation. Some adverse effects, particularly flushing, are more common ...
Cholesterol management guidelines from the American College of Cardiology/American Heart Association Task Force were last published in 2019.
Med Lett Drugs Ther. 2022 Sep 19;64(1659):145-52 |  Show IntroductionHide Introduction

Drugs for Osteoarthritis

   
The Medical Letter on Drugs and Therapeutics • Apr 20, 2020  (Issue 1596)
site, and the dried residue can cause coughing, sneezing, and eye irritation.25 Because of the risk ...
Many different drugs are used for treatment of osteoarthritis pain, but none of them prevent progression of the disease. Nonpharmacologic approaches including weight management, exercise, tai chi, physical therapy, assistive devices, and total joint arthroplasty can also be used. The American College of Rheumatology (ACR) has published new guidelines for the management of osteoarthritis of the hip, hand, and knee.
Med Lett Drugs Ther. 2020 Apr 20;62(1596):57-62 |  Show IntroductionHide Introduction

Drugs That May Cause Psychiatric Symptoms

   
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008  (Issue 1301)
, paranoia, agitation, scopolamine anxiety Sudden incoherent speech, delirium with high From eye drops ...
Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.

Click here to view the free full article.
Med Lett Drugs Ther. 2008 Dec 15;50(1301):100-3 |  Show IntroductionHide Introduction

Cannabis and Cannabinoids

   
The Medical Letter on Drugs and Therapeutics • Nov 18, 2019  (Issue 1585)
, and nabiximols. Other adverse effects of these drugs include dry mouth, nausea, vomiting, and fatigue. Local ...
Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of cannabis. CBD, unlike THC, does not produce intoxication or euphoria.
Med Lett Drugs Ther. 2019 Nov 18;61(1585):179-82 |  Show IntroductionHide Introduction